Philip Redpath
Impact in
- Geriatrics and Gerontology top 0.1%
- Sirtuins and Resveratrol in Medicine
- Physiology top 0.1%
- Calcium signaling and nucleotide metabolism
- Adipose Tissue and Metabolism
- Adenosine and Purinergic Signaling
Papers in
-
- Sirtuins and Resveratrol in Medicine 9
-
- Chemical Synthesis and Analysis 3
- Biochemical and Molecular Research 2
- Co-authors
- Marie E. Migaud (16 shared papers)Charles Brenner (5 shared papers)Samuel A.J. Trammell (4 shared papers)Ryan W. Dellinger (2 shared papers)Karthikeyani Chellappa (3 shared papers)Rajendra S. Apte (1 shared paper)Shin‐ichiro Imai (1 shared paper)Shunsuke Kubota (1 shared paper)
- Journals
- Cell Metabolism (3 papers)Nature Communications (2 papers)Molecular Pharmaceutics (1 paper)Organic Letters (1 paper)RSC Advances (1 paper)
- Partner nations
- United KingdomUnited StatesChina
In The Last Decade
Philip Redpath
17 papers receiving 2.6k citations
Philip Redpath's Hit Papers
Peers
Comparison fields: 5 of 105
- Geriatrics and Gerontology 1.4k
- Physiology 912
- Biological Psychiatry 215
- Aging 98
- Oncology 820
Countries citing papers authored by Philip Redpath
This map shows the geographic impact of Philip Redpath's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Philip Redpath with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Philip Redpath more than expected).
Fields of papers citing papers by Philip Redpath
This network shows the impact of papers produced by Philip Redpath. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Philip Redpath. The network helps show where Philip Redpath may publish in the future.
Co-authors
The 25 scholars most cited alongside Philip Redpath, linked wherever they have co-authored with each other. Click a name or a connecting line to browse the papers they share.
All Works
| # | Work | ||
|---|---|---|---|
| 1 | Long-Term Administration of Nicotinamide Mononucleotide Mitigates Age-Associated Physiological Decline in Mice Hit paper breakdown → | 2016 | 628 |
| 2 | Nicotinamide riboside is uniquely and orally bioavailable in mice and humans Hit paper breakdown → | 2016 | 493 |
| 3 | Quantitative Analysis of NAD Synthesis-Breakdown Fluxes Hit paper breakdown → | 2018 | 370 |
| 4 | 2016 | 273 | |
| 5 | 2016 | 270 | |
| 6 | 2014 | 176 | |
| 7 | 2018 | 109 | |
| 8 | 2016 | 92 | |
| 9 | 2017 | 90 | |
| 10 | 2015 | 64 | |
| 11 | 2016 | 32 | |
| 12 | 2015 | 19 | |
| 13 | 2008 | 15 | |
| 14 | 2021 | 14 | |
| 15 | 2015 | 13 | |
| 16 | 2014 | 5 | |
| 17 | 2012 | 5 |
About Philip Redpath
Philip Redpath is a scholar working on Geriatrics and Gerontology, Molecular Biology, Physiology, Oncology and Organic Chemistry, having authored 17 papers that have together received 2.7k indexed citations. Recurring topics across this work include Sirtuins and Resveratrol in Medicine (9 papers), Calcium signaling and nucleotide metabolism (7 papers), PARP inhibition in cancer therapy (5 papers), Chemical Synthesis and Analysis (3 papers), Biochemical and Molecular Research (2 papers), Carbohydrate Chemistry and Synthesis (2 papers), Boron Compounds in Chemistry (1 paper) and Microbial Natural Products and Biosynthesis (1 paper). The work is most often cited by research in Geriatrics and Gerontology (1.4k citations), Physiology (912 citations), Biological Psychiatry (215 citations), Aging (98 citations) and Oncology (820 citations). Philip Redpath has collaborated with scholars based in United Kingdom, United States and China. Frequent co-authors include Marie E. Migaud, Charles Brenner, Samuel A.J. Trammell, Ryan W. Dellinger, Karthikeyani Chellappa, Rajendra S. Apte, Shin‐ichiro Imai, Shunsuke Kubota, Shohei Yoshida and Joshua D. Rabinowitz. Their work appears in journals such as Cell Metabolism, Nature Communications, Molecular Pharmaceutics, Organic Letters and RSC Advances.
Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.